Drug Recall
Alcon recalls one lot of Systane single-use eye drops due to fungal contamination
Alcon Laboratories announced the voluntary recall of one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, following a consumer complaint that led to the discovery of fungal contamination in the drops.
Brassica Pharma recalls eye ointment products due to lack of sterility assurance
Brassica Pharma has initiated a voluntary recall of its eye ointment products after an FDA inspection of a Brassica facility found a “lack of sterility assurance.”
Oral solution of levothyroxine sodium recalled due to possible subpotent doses
A voluntary recall has been issued for an oral solution of levothyroxine sodium due to possible subpotency among some of the manufactured products, according to a company press release.
Top in cardiology: Atrial fibrillation in firefighters, Pfizer recall of BP medications
Firefighters who responded to a higher number of fires per year had a significantly greater risk for developing atrial fibrillation than those who responded to fewer fires, according to a recent study.
Voluntary safety recall of contaminated metformin products
Viona Pharmaceuticals, Inc., is voluntarily recalling 33 lots of metformin hydrochloride extended-release tablets, USP 750 mg, due to presence of N-Nitrosodimethylamine, or NDMA, according to a company statement.
Lupin recalls irbesartan tablets due to possible carcinogenic contamination
Lupin is voluntarily recalling batches of irbesartan and irbesartan/hydrochlorothiazide tablets after an analysis revealed that certain tested active pharmaceutical ingredient batches had too much N-nitrosoirbesartan.
Nostrum Laboratories issues voluntary recall of contaminated metformin products
Nostrum Laboratories, Inc., is voluntarily recalling two lots of metformin hydrochloride extended-release tablets that contain unacceptable levels of the nitrosamine impurity N-Nitrosodimethylamine, or NDMA, according to an FDA statement.
FDA requests voluntary recall of contaminated metformin products
The FDA has asked five drug manufacturers to voluntarily recall several lots of extended-release metformin after agency lab testing revealed unacceptable levels of the nitrosamine impurity N-Nitrosodimethylamine, or NDMA.
FDA requests withdrawal of weight-loss drug due to cancer risk
The FDA requested that the manufacturer of the serotonin receptor agonist lorcaserin voluntarily withdraw the weight-loss drug from the U.S. market because of clinical trial data that show an increased occurrence of cancer, according to an agency alert issued today.
Angiotensin receptor antagonist use decreased after recalls for potentially carcinogenic impurities
The use of angiotensin II receptor antagonists, particularly generic valsartan, losartan and irbesartan, decreased since being recalled for potentially carcinogenic impurities, according to a research letter published in JAMA.